Cipla recalls diclofenac sodium 1% topical gel over failed pH specifications
The 100 g tubes of diclofenac sodium topical gel, 1%, did not meet the required pH specifications, according to the recall notice.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
- Company
- Cipla USA, Inc.
- Hazard
- Failed PH Specifications
- Units
- 92,376 tubes
- Where sold
- Nationwide in the USA
- FDA classification
- Class III · Ongoing
- Classified by FDA
- January 20, 2026
- Recall started
- December 22, 2025
- FDA enforcement report
- January 28, 2026
- Identifiers
- Codes: Batch XHBG; Exp. 08/31/2027
- FDA recall number: D-0291-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
- Reason for recall
- Failed PH Specifications
- Classification
- Class III (Ongoing)
- Distribution
- Nationwide in the USA
- Quantity
- 92,376 tubes
Related recalls
Water-Jel recalls CVS Lidocaine Wound Gel over failed pH specifications
The 0.5 oz (14 g) tubes of Lidocaine Wound Gel sold under the CVS Pharmacy name failed pH specifications, meaning the gel's acidity did not meet the required standard.
Water-Jel Technologies, LLC · 31,488 tubes